Comparing different LaserCap devices for hair growth in androgenetic alopecia
Effect of Increasing Fluence on Efficacy of Low Level Laser Therapy for Androgenetic Alopecia, a Randomized Control Trial
This study tests which of three different LaserCap devices can help men and women aged 25 and older with hair loss from androgenetic alopecia grow more hair.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 25 Years and up |
| Sex | All |
| Sponsor | University of Arizona Academic / other |
| Locations | 1 site (Tucson, Arizona) |
| Trial ID | NCT05365360 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of three different LaserCap devices—LaserCap SD, LaserCap HD+, and a Sham LaserCap—in treating androgenetic alopecia (AGA). Participants aged 25 and older, both men and women, will be recruited to assess the impact of low-level laser therapy on hair growth. The study aims to compare the fluence levels of these devices to determine which is most effective in promoting hair density. The trial will include individuals with varying stages of AGA, ensuring a comprehensive analysis of treatment outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are men and women aged 25 and older with diagnosed androgenetic alopecia who have not received any treatment for the condition in the past six months.
Not a fit: Patients with advanced stages of androgenetic alopecia or those currently using other treatments for hair loss may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective non-invasive treatment option for patients suffering from hair loss due to androgenetic alopecia.
How similar studies have performed: Previous studies have shown positive outcomes with low-level laser therapy for hair growth, but this specific comparison of different fluences is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * 25 years and older * Men and women with AGA, untreated or with 6-month washout of previous treatments * Men: Norwood stage IIa - V * Women: Ludwig I-1 - II-2, or frontal pattern * All patients: Fitzpatrick skin types I to IV Exclusion criteria: * Men: Norwood stage Va, VI, VII * Women: Ludwig stage III, advanced * All patients: Fitzpatrick skin types V, VI * Current use or within the past six month of other treatment for AGA, including topical and oral minoxidil, topical and oral finasteride and dutasteride * Age 0-25 years
Where this trial is running
Tucson, Arizona
- Banner University Dermatology — Tucson, Arizona, United States (Recruiting)
Study contacts
- Study coordinator: Patrick Jedlowski, MD
- Email: pjedlowski@email.arizona.edi
- Phone: (520) 694-8888
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.